Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 7Neoplasms 2Leiomyosarcoma 2Wilms Tumor 1Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor, Protocol Specific 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Neuroblastoma 1Neoplasms, Connective and Soft Tissue 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Lung Neoplasms 1Liver Diseases 1Liposarcoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hepatic Insufficiency 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Bone Neoplasms 1

Interventions

copanlisib 1cc-486 1alisporivir 1Trabectedin 1Dexamethasone 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Hepatic Insufficiency × Trabectedin × Clear all
NCT01273493 2016-02-15

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Janssen Research & Development, LLC

Phase 1 Completed
15 enrolled

Liver Diseases, Neoplasm Metastasis, Hepatic Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡